13.9 C
New York
Tuesday, May 18, 2021

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone

Must read

Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective

Stock Markets6 minutes ago (May 18, 2021 07:36AM ET) (C) Reuters. A box and a vial of AstraZeneca's COVID-19 vaccine are seen in a general...

Dollar slumps to multi-month lows as expectations of flat rates cement

Economy7 minutes ago (May 18, 2021 07:36AM ET) (C) Reuters. FILE PHOTO: A packet of former U.S. President Abraham Lincoln five-dollar bill currency is inspected...

Macy’s raises annual forecast as people return to stores

Economy7 minutes ago (May 18, 2021 07:35AM ET) (C) Reuters. FILE PHOTO: Shoppers are seen outside Macy's in the Manhattan borough of New York City,...

Exclusive: G20 snubs COVID patent waiver, waters down pledge on WHO’s funding – draft

(C) Reuters. FILE PHOTO: Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken...
imageStock Markets38 minutes ago (Aug 24, 2020 04:05AM ET)

(C) Reuters. FILE PHOTO: Takeda Pharmaceutical’s logo is seen at its headquarters in Tokyo

TOKYO (Reuters) – Takeda Pharmaceutical Co said on Monday it has agreed to sell its Japanese consumer healthcare business to U.S. investment fund Blackstone Group (NYSE:BX).

Takeda Consumer Healthcare Company, which makes over-the-counter (OTC) drugs and health products, is valued at 242 billion yen ($2.29 billion) and the sale price will be determined after calculating its debt and other factors, Takeda said.

Japan’s largest pharmaceuticals company has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt following its $59 billion acquisition of Shire.

Blackstone was among the final bidders for the OTC unit, Reuters reported in June, along with Bain Capital, CVC Capital Partners and Taisho Pharmaceutical Holdings Co Ltd.

Takeda said proceeds from the sale would boost its net profit by 105 billion yen. The transaction is expected close by March 31, subject to regulatory closing conditions, it said.

The deal follows Blackstone’s acquisition of Japan’s Ayumi Pharmaceutical Corp for $1 billion in March 2019.

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective

Stock Markets6 minutes ago (May 18, 2021 07:36AM ET) (C) Reuters. A box and a vial of AstraZeneca's COVID-19 vaccine are seen in a general...

Dollar slumps to multi-month lows as expectations of flat rates cement

Economy7 minutes ago (May 18, 2021 07:36AM ET) (C) Reuters. FILE PHOTO: A packet of former U.S. President Abraham Lincoln five-dollar bill currency is inspected...

Macy’s raises annual forecast as people return to stores

Economy7 minutes ago (May 18, 2021 07:35AM ET) (C) Reuters. FILE PHOTO: Shoppers are seen outside Macy's in the Manhattan borough of New York City,...

Exclusive: G20 snubs COVID patent waiver, waters down pledge on WHO’s funding – draft

(C) Reuters. FILE PHOTO: Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken...

Jaguar Land Rover parent logs March-quarter loss

Stock Markets11 minutes ago (May 18, 2021 07:31AM ET) 2/2 (C) Reuters. FILE PHOTO: A Tata Tigor car is pictured at the assembly line inside the...